Last reviewed · How we verify
NCT06614023
Impact of Body Weight on Outcomes of Patients Undergoing Coronary Artery Bypass Grafting
trial testing coronary artery bypass grafting in Obesity in 6,448 participants. Completed in 1 February 2022.
30 September 2020
Quick facts
| Lead sponsor | Medical University of Silesia |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 6,448 |
| Start date | 1 January 2014 |
| Primary completion | 30 September 2020 |
| Estimated completion | 1 February 2022 |
Drugs / interventions tested
- coronary artery bypass grafting
Conditions studied
- Obesity — all drugs for Obesity →
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
- Angina Pectoris — all drugs for Angina Pectoris →
- Coronary; Ischemic — all drugs for Coronary; Ischemic →
Sponsor
Medical University of Silesia
Who can join
18 and older, any sex, with Obesity or Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
All consecutive patients who underwent isolated coronary artery bypass grafting (CABG) at our institution from 2014 to 2020 were included. Patients were divided into 6 groups according to body mass index (BMI): underweight (BMI \<20.0 kg/m2), normal weight (BMI 20.0-24.9 kg/m2), overweight (BMI, 25-29.9 kg/m2), obesity class I (BMI 30-34.9 kg/m2), obesity class II (BMI 35-39.9 kg/m2) and obesity class III (BMI \>40 kg/m2). The long-term mortality was analyzed as primary end-point. The univariable and multivariable analysis was performed using logistic regression modeling.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of body mass index on long-term mortality after coronary artery bypass grafting: a retrospective cohort study.
Bis J, Kania-Olejnik P, Padaż K, Malinowski M, et al · · 2025 · PMID 40851956 · DOI 10.1097/ms9.0000000000003432
Verify or expand the search:
- PubMed search for NCT06614023
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of coronary artery bypass grafting
Trials testing the same drug.
- NCT06215300 — The Effect of Polymorphism of the GUCY1A3 rs7692387 Gene on Cardiovascular Events After Coronary Artery Bypass Grafting. · unknown
- NCT04916912 — Results of Coronary Artery Bypass Grafting in Obese Patients · completed
- NCT06749171 — Coronary Revascularization Outcomes Within Necessary Sex and Gender Aspects · completed
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Medical University of Silesia trials
Trials by the same sponsor.
- NCT06212674 — Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients · Phase 4 · recruiting
- NCT06970002 — Respiratory Stabilization in Chronic Acidosis Before Bronchofiberoscopy & Non-Invasive Ventilation Effectivenes · NA · not yet recruiting
- NCT07137299 — POPQ Associated With Total Laparoscopic Hysterectomy · not yet recruiting
- NCT06970041 — To Assess the Types of Mechanical Ventilation in Enabling Therapeutic Bronchofiberoscopy in Patients With Decompensated · NA · not yet recruiting
- NCT07120529 — Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective M · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06614023 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Silesia
- Last refreshed: 26 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06614023.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing